{"id":"W3164065928","doi":"10.1002/psp4.12647","title":"Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Sanofi Genzyme; Grifols; Mitsubishi Tanabe Pharma Corporation; CSL Behring; Baxalta; Argenx; European Commission; TG Therapeutics; Sanofi","keywords":"Chronic inflammatory demyelinating polyneuropathy; Dosing; Medicine; Antibody; Placebo; Polyradiculoneuropathy; Immunoglobulin E; Immunology; Population; Internal medicine; Polyneuropathy; Pharmacodynamics; Pharmacokinetics; Immunoglobulin G; Gastroenterology; Guillain-Barre syndrome; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.002996247,0.0008085855,0.002615222,0.006913872,0.0002712624,0.0001437246,0.0007524558,0.0003917979,0.0006150053],"category_scores_gemma":[0.001613624,0.0008145078,0.00114913,0.02588126,0.0001428248,0.0002672131,0.0006802555,0.002149274,0.0002020598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0010854,"about_ca_system_score_gemma":0.00101141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008664877,"about_ca_topic_score_gemma":0.00001962989,"domain_scores_codex":[0.9906291,0.001909594,0.00307736,0.001612423,0.001087628,0.001683891],"domain_scores_gemma":[0.9944474,0.002340618,0.0007088685,0.0007361976,0.0007288238,0.001038148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007024848,0.001859162,0.8812791,0.000580156,0.002953477,0.004400519,0.0002562428,0.01847741,0.07138296,0.00002108105,0.001823824,0.01626365],"study_design_scores_gemma":[0.04293462,0.002551031,0.8129637,0.0002671281,0.008025088,0.0004367673,0.0006107034,0.03263402,0.007933349,0.00000590531,0.08938644,0.00225125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9666854,0.02088862,0.0009593266,0.0008541343,0.008196197,0.001602711,0.00005073659,0.000322537,0.0004403382],"genre_scores_gemma":[0.9878021,0.00379334,0.0002370373,0.005668225,0.001423026,0.0001614792,0.00007500371,0.0001420983,0.0006977114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08756261,"threshold_uncertainty_score":0.9994306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03899096057079242,"score_gpt":0.3857171452933122,"score_spread":0.3467261847225198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}